| Year |
Citation |
Score |
| 2022 |
Hadi Ali Janvand S, Ladefoged LK, Zubrienė A, Sakalauskas A, Christiansen G, Dudutienė V, Schiøtt B, Matulis D, Smirnovas V, Otzen DE. Inhibitory effects of fluorinated benzenesulfonamides on insulin fibrillation. International Journal of Biological Macromolecules. 227: 590-600. PMID 36529223 DOI: 10.1016/j.ijbiomac.2022.12.105 |
0.484 |
|
| 2022 |
Ladefoged LK, Koch R, Biggin PC, Schiøtt B. Binding and Activation of Serotonergic G-Protein Coupled Receptors by the Multimodal Antidepressant Vortioxetine. Acs Chemical Neuroscience. 13: 1129-1142. PMID 35348335 DOI: 10.1021/acschemneuro.1c00029 |
0.571 |
|
| 2021 |
Ladefoged LK, Schiøtt B, Fedosova NU. Beneficent and Maleficent Effects of Cations on Bufadienolide Binding to Na,K-ATPase. Journal of Chemical Information and Modeling. PMID 33502848 DOI: 10.1021/acs.jcim.0c01396 |
0.541 |
|
| 2020 |
Cheng B, Morstein J, Ladefoged LK, Maesen JB, Schiøtt B, Sinning S, Trauner D. A Photoswitchable Inhibitor of the Human Serotonin Transporter. Acs Chemical Neuroscience. PMID 32275382 DOI: 10.1021/Acschemneuro.9B00521 |
0.583 |
|
| 2019 |
Munro L, Ladefoged LK, Padmanathan V, Andersen S, Schiott B, Kristensen AS. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage Clamp Fluorometry. Molecular Pharmacology. PMID 31582575 DOI: 10.1124/Mol.119.116657 |
0.594 |
|
| 2019 |
Zeppelin T, Ladefoged LK, Sinning S, Schiøtt B. Substrate and inhibitor binding to the serotonin transporter: insights from computational, crystallographic, and functional studies. Neuropharmacology. PMID 30807752 DOI: 10.1016/j.neuropharm.2019.02.030 |
0.679 |
|
| 2018 |
Ladefoged LK, Munro L, Pedersen AJ, Balle T, Bang-Andersen B, Lummis SCR, Schiott B, Kristensen AS. Modeling and mutational analysis of the binding mode for the multimodal antidepressant drug vortioxetine to the human 5-HT3A receptor. Molecular Pharmacology. PMID 30257860 DOI: 10.1124/Mol.118.113530 |
0.613 |
|
| 2018 |
Ladefoged LK, Zeppelin T, Schiøtt B. Molecular modeling of neurological membrane proteins - from binding sites to synapses. Neuroscience Letters. PMID 29802917 DOI: 10.1016/j.neulet.2018.05.034 |
0.654 |
|
| 2018 |
Zeppelin T, Ladefoged LK, Sinning S, Periole X, Schiøtt B. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. Plos Computational Biology. 14: e1005907. PMID 29329285 DOI: 10.1371/Journal.Pcbi.1005907 |
0.668 |
|
| 2016 |
Andersen J, Ladefoged LK, Kristensen TN, Munro L, Grouleff J, Stuhr-Hansen N, Kristensen AS, Schiøtt B, Strømgaard K. Interrogating the molecular basis for substrate recognition in serotonin and dopamine transporters with high-affinity substrate-based bivalent ligands. Acs Chemical Neuroscience. PMID 27425420 DOI: 10.1021/Acschemneuro.6B00164 |
0.694 |
|
| 2015 |
Grouleff J, Ladefoged LK, Koldsø H, Schiøtt B. Monoamine transporters: insights from molecular dynamics simulations. Frontiers in Pharmacology. 6: 235. PMID 26528185 DOI: 10.3389/Fphar.2015.00235 |
0.653 |
|
| 2015 |
Andersen J, Ladefoged LK, Wang D, Kristensen TN, Bang-Andersen B, Kristensen AS, Schiøtt B, Strømgaard K. Binding of the Multimodal Antidepressant Drug Vortioxetine to the Human Serotonin Transporter. Acs Chemical Neuroscience. PMID 26389667 DOI: 10.1021/Acschemneuro.5B00225 |
0.698 |
|
| 2014 |
Wilson JN, Ladefoged LK, Babinchak WM, Schiøtt B. Binding-induced fluorescence of serotonin transporter ligands: A spectroscopic and structural study of 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) and APP(+) analogues. Acs Chemical Neuroscience. 5: 296-304. PMID 24460204 DOI: 10.1021/Cn400230X |
0.629 |
|
| Show low-probability matches. |